Remove 2018 Remove Generic Medicine Remove Pharmaceutical Companies
article thumbnail

The rise of Fixed-Dose Combinations (FDCs): What it means for pharma players

Express Pharma

Additionally, pharmaceutical companies have increasingly turned to FDCs as a way to differentiate their products in a highly competitive market. By introducing unique formulations that combine existing drugs, companies can extend product life cycles and maintain exclusivity over certain combinations.

article thumbnail

The critical role of the generics sector during the pandemic

pharmaphorum

During this time, the role and responsibility of generics suppliers and manufacturers has been brought into stark perspective as one of the leading contributors in this industry-wide effort. The pandemic has further highlighted how research is not strictly limited to large, “innovator” pharmaceutical companies. About the author.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Koye Pharma allies with Sonde on vocal biomarkers for COPD

pharmaphorum

The new partnership “marks a major milestone in Sonde Health’s growth and evolution,” according to the company’s chief executive David Liu.

article thumbnail

Is India capable of ensuring equitable access to biopharmaceuticals?

Express Pharma

In a bid to resolve both physical and financial restrictions inhibiting equitable access to quality medicines, the Jan Aushadhi scheme was launched in 2008 and envisaged the setting up of dedicated Janaushadhi Kendras to provide quality generic medicines at capped prices for the general public.